4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001179110-15-008249
CIK 0001600132operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 8:31 PM ET
Size
5.4 KB
Accession
0001179110-15-008249
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2015-05-18+10,000→ 10,000 totalExercise: $8.20Exp: 2025-05-17→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 18, 2015. This option vests in four equal annual installments over a four-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 8:31 PM ET
- Size
- 5.4 KB